Weiwei Jin, MD1, Chao Lu, MS2, Yiping Mou, MD, FACS2, Xiaowu Xu2, Renchao Zhang2. 1Zhejiang Univerisity School of Medicin, Zhejiang Provincial People’s Hosptial, 2Zhejiang Provincial People’s Hosptial
Background: Pancreatic cancer is one of the most lethal cancers in the world with increasing incidence. Approximately 80% of pancreatic cancers are metastatic or local advanced. Laparoscopic pancreaticoduodenectomy (LPD) has been proven with the advantage of less blood loss, earlier recovery, better cosmesis. Whether LPD is safe and feasible for borderline resectable pancreatic cancer is still uncertain.
Methods: Analyze the prospective data of patients who were diagnosed as borderline resectable pancreatic cancer and then underwent laparoscopic pancreaticoduodenectomy with “Easy First” strategy retrospectively.
Results: Total 18 patients with borderline resectable pancreatic cancer undergoing LPD from June 2013 to December 2015 were enrolled. Conversion to open procedure was required in 4 cases (22.2%) and laparoscopic total pancreatectomy was required in 1 case. The average operation time was (379.2±51.7)min, and blood loss was (340.6±280.6)ml.Total complication rate was 55.5% (10/18), with 2 cases of pancreatic leakage grade B, 3 cases for hemorrhage, 3 cases for bile leakage, 1 case for infection and 1 case for delayed gastric emptying. The average length of hospital stay was (20.7±9.6) days. The perioperative mortality was 0%. All patients were diagnosed as pancreatic adenocarcinomas pathologically and the average harvested lymph nodes were (16.3±7.6). The medium follow-up was 24 (8-36) months, 12 patients were still living with no evidence of recurrence, and 6 patients were suffered local recurrence or metastasis with 2 of them died.
Conclusions: Laparoscopic pancreaticoduodenectomy with ‘Easy First’ strategy is safe and feasible for borderline resectable pancreatic cancer with acceptable oncologic outcomes.
Keywords: Laparoscopic surgery; pancreaticoduodenectomy; pancreatic cancer; oncologic outcomes
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 79907
Program Number: P622
Presentation Session: Poster (Non CME)
Presentation Type: Poster
